Centralized healthcare systems to be the centre point of Veterinary Molecular Diagnostics Market

The Veterinary Molecular Diagnostics Market is likely to grow on a robust note in the next decade. The next decade would be seeing the integration of telehealth services with the physical ones that exist at the moment. Urgent care and primary care are bound to be accessed through virtual visits, along with improvement in collaboration with the clinics, dialysis centres, long-term care facilities, and mental health services. This shifting is to be witnessed in the healthcare vertical shortly.
Rise in population has led to significant increase in the amount of meat and dairy consumption across the world. In addition, growing concerns over the consumption of healthy meat and dairy products is also soaring high. Rising concerns about veterinary health in both, livestock as well as companion animals, are also leading the veterinary molecular diagnostics market toward significant growth. In America, the American Veterinary Medical Association conducts various awareness programs, and such efforts by organizations to create awareness are boosting the growth of the veterinary molecular diagnostics market.

To remain ‘ahead’ of your competitors, request for a sample@ https://www.persistencemarketresearch.com/samples/12874

However, the outbreak of COVID-19 in December 2019 has led to social distancing and lockdowns in more than 100 countries across the world. This has disrupted the supply chain of the market, thereby imparting a negative impact. The impact of COVID-19 is significant, and is expected to continue to be felt on the veterinary molecular diagnostics market in 20201 as well.

Persistence Market Research predicts that, the global veterinary molecular diagnostics market will exhibit a CAGR of around 8% during the forecast period (2020-2030).

Company Profiles:

Cree, Inc.
GE Lighting LLC
Philips Lumiled Lighting Company
OSRAM Light AG
Samsung Groups
Epistar corporation
Toshiba Lighting and Technology Corporation
Verbatim Ltd
Cooper Industries Plc
Galaxia

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/12874

Key Takeaways from Veterinary Molecular Diagnostics Market Study

In terms of product, PCR Kits dominate the veterinary molecular diagnostics market share, and this trend is expected to continue during the forecast period, due to reliable results and cost-effective properties of the product.
In terms of disease, the new castle diseases segment is expected to hold more than 25% of the veterinary molecular diagnostics market, expanding at a CAGR of 8%.
Based on species, the livestock segment is expected to experience maximum growth during the forecast period, due to increasing dairy farming activities in countries with high demand for dairy products.
By end user, veterinary hospitals represented the highest revenue share of 50% in 2019, and are expected to continue dominating the veterinary molecular diagnostics market during the forecast period as well.
North America generated the highest revenue share of 39.4% in 2019, due to rising adoption of pets and presence of key players in the region. Europe is the 2nd most lucrative region with a revenue share of 28.4%.
The outbreak of COVID-19 has had a negative impact on the overall veterinary molecular diagnostics market.
“Increasing prevalence of veterinary diseases coupled with growing acceptance of molecular diagnostic techniques is expected to boost the growth of the veterinary molecular diagnostics market over the years to come,” says a PMR analyst.

Get a Customized Scope to Match Your Need Ask an Expert- sales@persistencemarketresearch.com

Rise in Consolidation Activities by Key Players

Key manufacturers in the global veterinary molecular diagnostics market are highly focused on adopting strategies that will have a positive impact on their product portfolio and as well as enhance their presence in the veterinary molecular diagnostics market. Manufacturers are actively implementing strategies such as collaborations, mergers, partnerships, and acquisitions, which is helping them create a stronger footprint in the global market.

For instance, Thermo Fisher Scientific Inc. acquired Qiagen N.V. in March 2020.
What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on veterinary molecular diagnostics market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of product (PCR kits, INAAT kits, microarray kits, and DNA sequencing kits), disease (anaplasma spp.,ehrlichia spp., new castle disease, influenza, porcine reproductive & respiratory syndrome (PRRS), and others), species (livestock animals and companion animals), and end user (veterinary hospitals, clinical laboratories, and veterinary research institutes), across seven key regions.

For in-depth competitive analysis, buy now @ https://www.persistencemarketresearch.com/checkout/12874

Complete Report Details@ https://www.persistencemarketresearch.com/market-research/veterinary-molecular-diagnostics-market.asp

Read More Trending "PMR Exclusive Article"-

North America Vet Compounding Pharmacies Market@ https://www.persistencemarketresearch.com/market-research/north-america-vet-compounding-pharmacies-market.asp

Aquaculture Feed and Pharmaceutical Market@ https://www.persistencemarketresearch.com/market-research/aquaculture-feed-and-pharmaceutical-market.asp

Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

About us-
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on “micros” by Persistence Market Research helps companies overcome their “macro” business challenges.

This release was published on openPR.